Navigation Links
Einstein receives nearly $5 million to study how Ebola causes infection

July 9, 2012 (Bronx, NY) The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine of Yeshiva University a five-year, $4.8 million grant to study the molecular mechanism that allows the Ebola virus to cause infection and spread in animals.

The Ebola virus is one of the world's deadliest viruses, causing fatal hemorrhagic fevers in humans and in primates. It is highly contagious, and there is no known cure. Ebola kills up to 90 percent of the people it infects.

The grant award builds on earlier groundbreaking research. Einstein scientists were part of a multi-institutional team that helped to identify the protein (Niemann-Pick C1 or NPC1) critical for infection by the Ebola virus. The team, led at Einstein by Kartik Chandran, Ph.D., associate professor of microbiology & immunology and principal investigator of the new NIH grant, showed that cells that did not make NPC1 could not be infected by Ebola. The findings were published last August in Nature. A follow-up paper from the same team, published in EMBO Journal, demonstrated that NPC1 is an essential receptor for entry of Ebola virus into cells.

The NIH grant will study the interaction between NPC1 and Ebola that lead to infection and determine how NPC1 functions as a critical receptor for the virus. Because such interactions are often crucial to the emergence and spread of a virus into new populations, Einstein researchers are also investigating NPC1's role in infection within different species that may harbor the virus in nature.

"To learn more about how the virus might jump from animals to humans, we're studying the interaction between the virus and NPC1 proteins in different animals, like bats and rodents, that are found in known Ebola hotspots," said Dr. Chandran. "Our understanding of what controls Ebola's emergence is limited and we hope that our project will pinpoint possible targets for antiviral drugs designed to combat it."

Other investigators on this grant are from The Scripps Research Institute and the University of California, San Diego. Global Viral Forecasting, a pandemic surveillance organization, will provide the samples from animals native to Ebola-endemic areas in central and West Africa.

The grant "Mechanism of receptor-mediated entry and infection by filoviruses" (AI101436) was awarded by National Institute of Allergy and Infectious Diseases, part of the NIH.


Contact: Kim Newman
Albert Einstein College of Medicine

Related medicine news :

1. Feinstein Institute to Receive Grant from Centers for Medicare & Medicaid Services to Improve Schizophrenia Treatment
2. Feinstein Institute to receive grant to improve schizophrenia treatment
3. Einstein awarded $6 million grant to develop new TB vaccine against drug-resistant strains
4. Eye doctor receives Visionary Award
5. Cuff Repair Plate™ Receives Design and Utility Patents
6. Special Needs Spotlight: Former SFMTA Board Member Bruce Oka Receives Treatment with San Francisco Sedation Dentist Dr. David Blende
7. Clifford Saper, MD, PhD, receives Distinguished Scientist Award from the Sleep Research Society
8. Johns Hopkins African bioethics program receives 5-year continuation grant from NIH
9. Aging Brain Care model receives $7.8 million in CMS innovation funding
10. The W3 Project Receives Support from Doulton for Emergency Relief Efforts
11. High value health care collaborative receives $26 million health care innovation grant
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... Ill. , June 23, 2016  In a startling report ... are failing their residents by lacking a comprehensive, proven plan to ... a definitive ranking of how states are tackling the worst ... to only four states – Kentucky , ... Vermont . Of the 28 failing states, three ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: